These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7651169)

  • 1. In vivo assays for farnesyltransferase inhibitors with Saccharomyces cerevisiae.
    Mitsuzawa H; Tamanoi F
    Methods Enzymol; 1995; 250():43-51. PubMed ID: 7651169
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Ras farnesyltransferase inhibitors by microbial screening.
    Hara M; Akasaka K; Akinaga S; Okabe M; Nakano H; Gomez R; Wood D; Uh M; Tamanoi F
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2281-5. PubMed ID: 8460134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of yeast for identification of farnesyltransferase inhibitors and for generation of mutant farnesyltransferases.
    Tamanoi F; Mitsuzawa H
    Methods Enzymol; 1995; 255():82-91. PubMed ID: 8524140
    [No Abstract]   [Full Text] [Related]  

  • 4. [Growth inhibition of human pancreatic cancer by farnesyl transferase inhibitor].
    Kainuma O; Asano T; Hasegawa M; Isono K
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1657-9. PubMed ID: 8886038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans.
    Hara M; Han M
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3333-7. PubMed ID: 7536929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of yeast farnesyltransferase from individually purified subunits.
    Urano J; Tamanoi F
    Methods Mol Biol; 1999; 116():145-59. PubMed ID: 10399151
    [No Abstract]   [Full Text] [Related]  

  • 7. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
    Cox AD; Der CJ
    Biochim Biophys Acta; 1997 Aug; 1333(1):F51-71. PubMed ID: 9294018
    [No Abstract]   [Full Text] [Related]  

  • 8. Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase.
    Caplin BE; Hettich LA; Marshall MS
    Biochim Biophys Acta; 1994 Mar; 1205(1):39-48. PubMed ID: 8142482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells.
    Pan J; She M; Xu ZX; Sun L; Yeung SC
    Cancer Res; 2005 May; 65(9):3671-81. PubMed ID: 15867362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl:protein transferase inhibitor.
    Ito T; Kawata S; Tamura S; Igura T; Nagase T; Miyagawa JI; Yamazaki E; Ishiguro H; Matasuzawa Y
    Jpn J Cancer Res; 1996 Feb; 87(2):113-6. PubMed ID: 8609057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of Ras farnesyltransferases.
    Tamanoi F
    Trends Biochem Sci; 1993 Sep; 18(9):349-53. PubMed ID: 8236454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note about computing all local alignments.
    Miller W; Boguski M
    Comput Appl Biosci; 1994 Jul; 10(4):455-6. PubMed ID: 7804880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein prenyltransferases.
    Casey PJ; Seabra MC
    J Biol Chem; 1996 Mar; 271(10):5289-92. PubMed ID: 8621375
    [No Abstract]   [Full Text] [Related]  

  • 17. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
    Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
    Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrastins A-C, new protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. I. Producing strain, fermentation, isolation, and biological activities.
    Omura S; Inokoshi J; Uchida R; Shiomi K; Masuma R; Kawakubo T; Tanaka H; Iwai Y; Kosemura S; Yamamura S
    J Antibiot (Tokyo); 1996 May; 49(5):414-7. PubMed ID: 8682716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases.
    Omer CA; Kral AM; Diehl RE; Prendergast GC; Powers S; Allen CM; Gibbs JB; Kohl NE
    Biochemistry; 1993 May; 32(19):5167-76. PubMed ID: 8494894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique sequence repeats in the alpha-subunit of protein farnesyltransferases.
    Feng XH; Kung SD
    Trends Biochem Sci; 1993 Nov; 18(11):426-7. PubMed ID: 8291087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.